1. (a) The pharmacist on duty shall report to the board by completing, and submitting, a New Hampshire “Controlled Drug Loss Form”, revised 5/2022, found online at https://www.oplc.nh.gov/state-pharmacy and submitting to the board through the mail to the address in Ph 103.03(a) or by email to pharmacy.compliance@oplc.nh.gov any theft or significant loss described in Ph 702.03(e) of controlled substances within one business day.
2. (b) All instances of diversion shall be reported within one business day.
3. (c) In addition to the initial report of loss required per section (a) above, the pharmacist who discovered the loss shall submit a final report on the loss by completing, and submitting, a New Hampshire “Controlled Drug Loss Form”, revised 5/2022 found online at https://www.oplc.nh.gov/state-pharmacy and submitting to the board through the mail to the address in Ph 103.03(a) or by email to pharmacy.compliance@oplc.nh.gov as soon as the investigation into the loss is complete but no later than 30 days after the discovery of the loss.
4. (d) A pharmacy shall keep a perpetual inventory for all Schedule II drugs and actual counts shall be verified monthly. The inventory reports shall be maintained for a minimum of 2 years and be readily available upon board inspection or request.

5. (e) A pharmacy shall consider a controlled drug loss to be significant when:

   1. (1) The percentage of dosage units of a specific drug exceeds 2% of monthly dispensing volume; or
   2. (2) Fifteen or more dosage units are not accounted for.

6. (f) The written report referenced in (a) shall contain at least the following:

   1. (1) Date of discovery;
   2. (2) The identity of the person making the discovery;
   3. (3) The name and location of the pharmacy from which the drug is missing;
   4. (4) Name, strength, dosage form, NDC and quantity of the missing drug(s); and
   5. (5) The cause of the controlled drug loss as determined by the investigation.
7. (g) After 3 significant losses described in Ph 702.03(e) within a 12-month period and after investigation, the pharmacist in charge and the permit holder shall present to the board an action plan to remedy the issue. The board shall require, if necessary, additional security measures to address the issue. Failure to do so shall be subject to disciplinary action as provided in RSA 318:29.

Source. #1639, eff 11-1-80; ss by #2260, eff 1-5-83; ss by #4600, eff 8-1-89; ss by #6094-B, INTERIM, eff 9-21-95, EXPIRED, 1-19-96 New. #6181-B, eff 2-5-96, EXPIRED: 2-5-04 New. #8316, eff 3-26-05, EXPIRED: 3-26-13 New. #10903, eff 8-5-15; ss by 13398, eff 6-22-22 (formerly Ph 703.03)